Metallo--lactamases (MLs) are zinc-dependent enzymes able to hydrolyze and inactivate most -lactam antibiotics. The large diversity of active site structures and metal content among MLs from different sources has limited the design of a pan-ML inhibitor. Here we report the biochemical and biophysical characterization of a novel ML, GOB-18, from a clinical isolate of a Gram-negative opportunistic pathogen, Elizabethkingia meningoseptica. Different spectroscopic techniques, three-dimensional modeling, and mutagenesis experiments, reveal that the Zn(II) ion is bound to Asp 120 , His 121 , His 263 , and a solvent molecule, i.e. in the canonical Zn2 site of dinuclear MLs. Contrasting all other related MLs, GOB-18 is fully active against a broad range of -lactam substrates using a single Zn(II) ion in this site. These data further enlarge the structural diversity of MLs.The expression of -lactam degrading enzymes (-lactamases) is the most common mechanism of antibiotic resistance among bacteria (1, 2). These enzymes have been grouped into four classes (A-D) according to sequence homology (3, 4). Class A, C, and D enzymes use an active site serine residue as a nucleophile, whereas class B lactamases (generically termed metallo--lactamases, MLs) 9 employ one or two Zn(II) ions to cleave the -lactam ring.MLs have particular importance in the clinical setting since they can hydrolyze a broader spectrum of -lactam substrates than the serine-type enzymes and are resistant to most clinically employed inhibitors (5-11). The design of an efficient pan-ML inhibitor has been mostly limited by a striking diversity in the active site structures, catalytic features, and metal ion requirements for activity among different enzymes. Based on this heterogeneity, MLs have been classified into three subclasses: B1, B2, and B3 (3, 6). Subclass B1 includes several chromosomally encoded enzymes such as BcII from Bacillus cereus (12-14), CcrA from Bacteroides fragilis (15-18), BlaB from Elizabethkingia meningoseptica (formerly, Chryseobacterium meningosepticum) (19), as well as the transferable VIM (20)-, IMP (21, 22)-, SPM (23, 24)-, and GIM-type enzymes. Subclass B2 includes the CphA (25, 26) and ImiS (27) lactamases from Aeromonas species. Subclass B3, originally represented only by L1 from Stenotrophomonas maltophilia (28 -30), now includes enzymes from other opportunistic pathogens like FEZ-1 from Legionella gormanii (31) and GOB from E. meningoseptica (32), as well as from environmental bacteria such as CAU-1 from Caulobacter crescentus (33) and THIN-B from Janthinobacterium lividum (34).Molecular structures of MLs from the three subclasses have been solved by x-ray crystallography (12,14,15,25,31). Comparison of the tertiary structure of enzymes belonging to the different subclasses reveals a common ␣/␣ sandwich fold, in which different insertions and deletions have resulted in different loop topologies and, ultimately, in different zinc coordination environments and metal site occupancies among B1, B2, and B3 en...